Neoadjuvant Therapy for Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is characterized by low resection and high postoperative recurrence rates, and conventional treatment strategies have failed to meet clinical needs. Neoadjuvant therapy (NAT) is widely employed in the routine management of several solid tumors because it increases rese...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Zongyi, Chen, Dongying, Liang, Shuang, Li, Xiaowu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9441170/
https://www.ncbi.nlm.nih.gov/pubmed/36068876
http://dx.doi.org/10.2147/JHC.S357313

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9441170/
https://www.ncbi.nlm.nih.gov/pubmed/36068876
http://dx.doi.org/10.2147/JHC.S357313

Ejemplares similares